- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
January 16th, 2007
The Wall Street Transcript has published an in-depth interview with Stephen M. Simes, president and CEO of BioSante Pharmaceuticals, Inc. (AMEX:BPA) in which he talks at length about the Company.
The entire 2,500 word interview is available free online at http://www.twst.com/ceos.htm.
BioSante is developing a pipeline of hormone therapy products to treat both men and women. BioSante's hormone therapy products are gel formulations for transdermal administration that deliver bioidentical estradiol and testosterone. The company also is developing its calcium phosphate nanotechnology (CaP) for novel vaccines, including avian flu and biodefense vaccines for toxins such as anthrax, and drug delivery systems.
|Related News Press|
Researchers develop new way to manufacture nanofibers May 21st, 2015
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
This Slinky lookalike 'hyperlens' helps us see tiny objects: The photonics advancement could improve early cancer detection, nanoelectronics manufacturing and scientists' ability to observe single molecules May 23rd, 2015
Detecting chemical weapons with a color-changing film January 28th, 2015
To Conserve London's 300-Year-Old Masterpiece, Nanotech & Drones April 12th, 2015
2015 Nanonics Image Contest January 29th, 2015